Edition:
United States

Surmodics Inc (SRDX.OQ)

SRDX.OQ on NASDAQ Stock Exchange Global Select Market

73.45USD
17 Aug 2018
Change (% chg)

$0.40 (+0.55%)
Prev Close
$73.05
Open
$73.10
Day's High
$73.45
Day's Low
$71.65
Volume
32,892
Avg. Vol
26,346
52-wk High
$73.85
52-wk Low
$24.60

Chart for

About

Surmodics, Inc. is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company's Medical Device segment consists of surface modification coating technologies to improve access, deliverability and... (more)

Overall

Beta: 0.58
Market Cap(Mil.): $980.67
Shares Outstanding(Mil.): 13.35
Dividend: --
Yield (%): --

Financials

  SRDX.OQ Industry Sector
P/E (TTM): -- 38.05 30.45
EPS (TTM): -0.09 -- --
ROI: -0.87 14.28 12.63
ROE: -1.01 17.47 14.82

BRIEF-Surmodics Says CFO Andrew Lafrence Resigned

* SURMODICS ANNOUNCES LEADERSHIP CHANGE AND APPOINTMENT OF INTERIM CFO

May 16 2018

BRIEF-Surmodics Acquires Thrombectomy Technology Assets

* SURMODICS ACQUIRES THROMBECTOMY TECHNOLOGY ASSETS FROM EMBOLITECH, STRENGTHENING PERIPHERAL VASCULAR WHOLE-PRODUCT SOLUTIONS PORTFOLIO

May 14 2018

BRIEF-Surmodics Reports Q2 Non-GAAP EPS $0.07

* SURMODICS REPORTS SECOND QUARTER FISCAL 2018 RESULTS, INCREASES FISCAL 2018 GUIDANCE

May 02 2018

BRIEF-Surmodics Announces FDA Clearance Of A New .018” Low-Profile Pta Balloon Dilation Catheter

* SURMODICS ANNOUNCES FDA CLEARANCE OF A NEW .018” LOW-PROFILE PTA BALLOON DILATION CATHETER

Apr 23 2018

BRIEF-Abbott And Surmodics Announce Agreement For Next-Generation Drug-Coated Balloon

* ABBOTT AND SURMODICS ANNOUNCE AGREEMENT FOR NEXT-GENERATION DRUG-COATED BALLOON

Feb 27 2018

Competitors

Earnings vs. Estimates